These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 12760496

  • 1. Differentiation of pituitary adenomas from other sellar and parasellar tumors by 99mTc(V)-DMSA scintigraphy.
    Yamamura K, Suzuki S, Yamamoto I.
    Neurol Med Chir (Tokyo); 2003 Apr; 43(4):181-6; discussion 187. PubMed ID: 12760496
    [Abstract] [Full Text] [Related]

  • 2. Technetium-99m pentavalent dimercaptosuccinic acid imaging in patients with pituitary adenomas.
    Lastoria S, Colao A, Vergara E, Ferone D, Varrella P, Merola B, Lombardi G, Salvatore M.
    Eur J Endocrinol; 1995 Jul; 133(1):38-47. PubMed ID: 7627336
    [Abstract] [Full Text] [Related]

  • 3. (99m)Technetium pentavalent dimercaptosuccinic acid scintigraphy in the follow-up of clinically nonfunctioning pituitary adenomas after radiotherapy.
    Colao A, Ferone D, Lombardi G, Lastoria S.
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):713-21. PubMed ID: 12072040
    [Abstract] [Full Text] [Related]

  • 4. Clinical usefulness of 99mTc-HYNIC-TOC, 99mTc(V)-DMSA, and 99mTc-MIBI SPECT in the evaluation of pituitary adenomas.
    Vukomanovic VR, Matovic M, Doknic M, Ignjatovic V, Simic Vukomanovic I, Djukic S, Peulic M, Djukic A.
    Nucl Med Commun; 2019 Jan; 40(1):41-51. PubMed ID: 30334858
    [Abstract] [Full Text] [Related]

  • 5. Preoperative Evaluation of Sellar and Parasellar Macrolesions by [18F]Fluorodeoxyglucose Positron Emission Tomography.
    Tosaka M, Higuchi T, Horiguchi K, Osawa T, Arisaka Y, Fujita H, Tsushima Y, Yoshimoto Y.
    World Neurosurg; 2017 Jul; 103():591-599. PubMed ID: 28427982
    [Abstract] [Full Text] [Related]

  • 6. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.
    Papantoniou V, Tsiouris S, Mainta E, Valotassiou V, Souvatzoglou M, Sotiropoulou M, Nakopoulou L, Lazaris D, Louvrou A, Melissinou M, Tzannetaki A, Pirmettis I, Koutsikos J, Zerva C.
    Breast Cancer Res; 2005 Jul; 7(1):R33-45. PubMed ID: 15642168
    [Abstract] [Full Text] [Related]

  • 7. Active inflammatory bowel disease: evaluation with 99mTc (V) DMSA scintigraphy.
    Koutroubakis IE, Koukouraki SI, Dimoulios PD, Velidaki AA, Karkavitsas NS, Kouroumalis EA.
    Radiology; 2003 Oct; 229(1):70-4. PubMed ID: 12925713
    [Abstract] [Full Text] [Related]

  • 8. Differential diagnosis of sellar masses.
    Freda PU, Post KD.
    Endocrinol Metab Clin North Am; 1999 Mar; 28(1):81-117, vi. PubMed ID: 10207686
    [Abstract] [Full Text] [Related]

  • 9. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
    Boni G, Ferdeghini M, Bellina CR, Matteucci F, Castro Lopez E, Parenti G, Canapicchi R, Bianchi R.
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):90-3. PubMed ID: 9002759
    [Abstract] [Full Text] [Related]

  • 10. Computed axial tomography of pituitary adenomas.
    Kuuliala I.
    Clin Radiol; 1981 May; 32(3):259-64. PubMed ID: 7237904
    [Abstract] [Full Text] [Related]

  • 11. Technetium-99m-pentavalent dimercaptosuccinic acid uptake in Hurthle cell tumor of the thyroid.
    Vergara E, Lastoria S, Varrella P, Lapenta L, Salvatore M.
    J Nucl Biol Med (1991); 1993 Jun; 37(2):65-8. PubMed ID: 8396979
    [Abstract] [Full Text] [Related]

  • 12. [Prolactin-secreting adenomas. Radiologic signs].
    Metzger J, Bonneville JF, Bugault R.
    Acta Radiol Suppl; 1976 Jun; 347():327-38. PubMed ID: 207114
    [Abstract] [Full Text] [Related]

  • 13. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
    Ergün EL, Kara PO, Gedik GK, Kars A, Türker A, Caner B.
    Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
    [Abstract] [Full Text] [Related]

  • 14. Pharyngeal pituitary non-functioning adenoma with normal intra-sellar gland: massive tumor shrinkage on octreotide therapy.
    Pugnale N, Waridel F, Bouzourène H, Boubaker A, Pugnale M, Gaillard RC, Gomez F.
    Eur J Endocrinol; 2003 Mar; 148(3):357-64. PubMed ID: 12611618
    [Abstract] [Full Text] [Related]

  • 15. Active inflammatory bowel disease: head-to-head comparison between 99mTc-hexamethylpropylene amine oxime white blood cells and 99mTc(V)-dimercaptosuccinic acid scintigraphy.
    Stathaki MI, Koutroubakis IE, Koukouraki SI, Karmiris KP, Moschandreas JA, Kouroumalis EA, Karkavitsas NS.
    Nucl Med Commun; 2008 Jan; 29(1):27-32. PubMed ID: 18049094
    [Abstract] [Full Text] [Related]

  • 16. Combined use of 99mTc-sestamibi and 99mTc-V-DMSA in the assessment of chemotherapy effectiveness in patients with multiple myeloma.
    Koutsikos J, Athanasoulis T, Anagnostopoulos A, Velidaki A, Passadi M, Dimopoulos MA, Zerva C.
    J Nucl Med; 2005 Jun; 46(6):978-82. PubMed ID: 15937309
    [Abstract] [Full Text] [Related]

  • 17. Use of 99mTc (V) DMSA scintigraphy in the detection and localization of intestinal inflammation: comparison of findings and colonoscopy and biopsy.
    Lee BF, Chiu NT, Wu DC, Tsai KB, Liu GC, Yu HS, Wang ST.
    Radiology; 2001 Aug; 220(2):381-5. PubMed ID: 11477240
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions.
    Massardo T, Alonso O, Kabasakal L, Llamas-Olier A, Shankar UR, Zhu H, Delgado L, González P, Mut F, Padhy AK.
    J Nucl Med; 2002 Jul; 43(7):882-8. PubMed ID: 12097457
    [Abstract] [Full Text] [Related]

  • 19. Pentavalent technetium-99m-dimercaptosuccinic acid scintigraphy in renal osteodystrophy.
    Higuchi T, Hirano T, Inoue T, Aoki J, Ueki K, Wakamatsu R, Yano S, Naruse T, Endo K.
    J Nucl Med; 1998 Mar; 39(3):541-3. PubMed ID: 9529307
    [Abstract] [Full Text] [Related]

  • 20. Scintigraphy with 99mTc(V)-DMSA in monitoring patients with inflammatory bowel disease.
    Javadi H, Amiriani T, Mirkarimi H, Besharat S, Semnani S, Abedi J, Seyedabadi M, Assadi M.
    Hell J Nucl Med; 2013 Mar; 16(3):209-12. PubMed ID: 24251309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.